Pharmacology of gap junctions in the cardiovascular system
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Gap junction channels provide the basis for intercellular communication and play an important physiological role in the cardiovascular system for maintenance of the normal cardiac rhythm, regulation of vascular tone, endothelial function and myoendothelial interaction as well as for metabolic interchange between the cells. Thus, pharmacological influence on these channels might help to elucidate their role in physiology and pathophysiology and might reveal new therapeutic approaches. The gap junction conductance between two cells is defined by the number of channels, the single channel conductance and the mean open and closed time. In principle, it is possible pharmacologically to induce closing of the channels, to change preferred single channel conductance, to open channels (or to keep them open), and to regulate the expression, synthesis, assembly and degradation of the channels thereby controlling the number of channels. This review describes the various substances affecting these parameters and outlines the possible pharmacological use of such drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impaired conduction of vasodilation along arterioles in connexin40-deficient mice
de Wit, C., Roos, F., Bolz, S.-S., Kirchhoff, S., Krüger, O., Willecke, K., & Pohl, U. (2000) · Circulation Research · doi:10.1161/01.res.86.6.649 · Cited by 338 · cited 2×
“Regarding the vasculature, it has been shown that EDHFresponses are attenuated if gap junctions are blocked and in Cx40 knock-out mice hypertension develops and upstream regulation of vasomotor tone is impaired [10] and that the tone of cerebral arteries can be attenuated by heptanol and 18-a-glycyrrhetinic acid.”
Cited by
Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor
Pelegrin, P., & Surprenant, A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601378 · Cited by 1,431
Pelegrin, P., & Surprenant, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610351200 · Cited by 302
MicroRNAs transfer from human macrophages to hepato-carcinoma cells and inhibit proliferation
Aucher, A., Rudnicka, D., & Davis, D. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301728 · Cited by 247
“Two other inhibitors of the gap junctions, 2-octanol and oleamide (31), also 6254 TRANSFER OF MACROPHAGE miRNA”
BackgroundConnexins: Key Mediators of Endocrine Function
Bosco, D., Haefliger, J.-A., & Meda, P. (2011) · Physiological Reviews · doi:10.1152/physrev.00027.2010 · Cited by 169
“The quite limited availability of such molecules is presently a major limitation in testing the functions of connexins (118, 119, 210, 244, 358, 377, 412, 425, 450, 488, 499, 512, 513, 546, 548).”
BackgroundResultZhu, Y., Gao, Y., Tao, C., Shao, M., Zhao, S., Huang, W., Yao, T., Johnson, J. A., Liu, T., Cypess, A. M., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.005 · Cited by 100
“…signals regulate Cx43 transcripts and channel activities? cAMP is a second messenger that is generated in cells receiving sympathetic neuronal input. cAMP activates the gap junction channel via phosphorylation and hemichannel assembly (Dhein, 2004; Nihei et al., 2010; TenBroek et al., 2001).”
BackgroundMethodInfluential
Metadata
- Authors
- Dhein, S.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-05-01
- Volume
- 62
- Issue
- 2
- Pages
- 287-298
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2120249750
- Cited by
- 83
- References
- 1
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacology of gap junctions in the cardiovascular system. https://app.cochat.ai/papers/10.1016/j.cardiores.2004.01.019
- The paper
- Dhein, S. (2004). Pharmacology of gap junctions in the cardiovascular system. Cardiovascular Research. https://doi.org/10.1016/j.cardiores.2004.01.019
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.